Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-491806
Filing Date
2016-03-03
Accepted
2016-03-03 17:21:13
Documents
145
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d102269d10k.htm 10-K 2729423
2 EX-10.15 d102269dex1015.htm EX-10.15 7751
3 EX-21 d102269dex21.htm EX-21 8380
4 EX-23 d102269dex23.htm EX-23 1338
5 EX-31.1 d102269dex311.htm EX-31.1 9378
6 EX-31.2 d102269dex312.htm EX-31.2 9357
7 EX-32.1 d102269dex321.htm EX-32.1 4300
14 GRAPHIC g102269g01k81.jpg GRAPHIC 56084
15 GRAPHIC g102269g44q67.jpg GRAPHIC 26053
  Complete submission text file 0001193125-16-491806.txt   14922088

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT bxlt-20151231.xml EX-101.INS 3295871
9 XBRL TAXONOMY EXTENSION SCHEMA bxlt-20151231.xsd EX-101.SCH 131382
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bxlt-20151231_cal.xml EX-101.CAL 175701
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bxlt-20151231_def.xml EX-101.DEF 830607
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxlt-20151231_lab.xml EX-101.LAB 1070328
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxlt-20151231_pre.xml EX-101.PRE 980810
Mailing Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Business Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015 224-940-2000
Baxalta Inc (Filer) CIK: 0001620546 (see all company filings)

EIN.: 471869689 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36782 | Film No.: 161482372
SIC: 2834 Pharmaceutical Preparations